A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma. - Huang AC; Orlowski RJ; Xu X; Mick R; George SM; Yan PK; Manne S; Kraya AA; Wubbenhorst B; Dorfman L; D'Andrea K; Wenz BM; et al. (Nature medicine, 2019)